Why a Soaring Education Stock at All-Time Highs Drew a New $3.5 Million Investment

Formula Growth disclosed a new third-quarter position in Laureate Education, acquiring 111,000 shares valued at roughly $3.5 million — about 1.25% of the fund's reportable U.S. equity assets — with the stake remaining outside its top five holdings. Laureate reported Q3 revenue of $400.2 million (up 9% YoY) and adjusted EBITDA of $94.8 million, with enrollments +6% YTD; the company ended the quarter with $241 million cash versus $102 million debt, raised full-year guidance and expanded its share repurchase authorization to $250 million, while its stock trades at $33.83 (+86% one year).

Analysis

Market structure: Laureate (LAUR) benefits directly—net cash ($241m), $250m buyback authorization and 6% YTD enrollment growth imply stronger pricing power in Latin America education niches (Mexico/Peru) and durable cash flows; competitors with heavier debt or weaker online footprints will cede share. The 86% one-year share move reduces float and increases implied volatility, tightening supply of free float while demand is driven by momentum and institutional accumulation (Formula Growth ~1.25% U.S. equity assets). FX exposure (MXN/PEN) is the main demand-supply swing factor for local-student affordability and revenues.

Risk assessment: Tail risks include adverse regulatory actions in Peru/Mexico (probability non-zero over 12–36 months), accreditation shocks, or a 10% EM enrollment shock that could cut revenue 6–8% and materially compress adjusted EBITDA margin from ~23% if fixed campus costs reassert. Near-term (days–weeks) expect volatility around earnings/guidance; medium-term (3–12 months) balance-sheet and buyback cadence validate free-cash conversion; long-term (12–36 months) hinges on sustained EM GDP/student affordability trends.

Trade implications: Direct play: size a conviction long with staggered buys (target 1–2% portfolio) and defined stops; prefer cost-efficient 9–12 month call spreads (e.g., buy 12m 35C / sell 55C) to cap downside while keeping upside to +40–60%. Pair: long LAUR vs short SPY (beta-adjusted) over 6–12 months to isolate idiosyncratic EDU upside. Hedge: buy FX puts or short MXN exposure if MXN/PEN fall >8% in 90 days.

Contrarian angles: Consensus prices growth optimism into a stretched valuation—buybacks reduce float but may crowd out reinvestment, raising execution risk. The market may be underpricing regulatory tail risk; conversely net-cash and 9% revenue YoY provide a valuation floor—mispricing window exists if enrollment sustains >5% YTD over next two quarters, which would imply further upside. Monitor monthly enrollment trends, buyback cadence and Peru policy developments for asymmetric entry points.

Key Decisions for Investors

• Establish a 1–2% portfolio long position in LAUR via staggered purchases (25% tranches over 6 weeks) with a 12-month horizon; set a hard stop-loss at 20% below entry (~$27 if entry ~ $34) and a target of +40–60% (~$47–$54).
• Implement a defined-risk options play: buy a 9–12 month call spread (example: buy 12m 35C / sell 55C) sized to 50% of the intended cash position to cap downside and preserve >2x asymmetric upside if enrollments hold.
• Execute a relative-value pair trade: go long LAUR and short SPY beta-adjusted (1:1 net exposure) for 6–12 months to harvest idiosyncratic outperformance; trim if LAUR underperforms SPY by >15% in 60 days.
• Risk triggers & hedges: reduce LAUR to 0.5% if quarterly revenue misses guidance by >4% or if net enrollment growth falls below 2% YTD; buy MXN/PEN downside protection or short local-currency exposure if MXN or PEN depreciate >8% vs USD within 90 days.